0001179110-15-012051.txt : 20150812
0001179110-15-012051.hdr.sgml : 20150812
20150812184608
ACCESSION NUMBER: 0001179110-15-012051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150810
FILED AS OF DATE: 20150812
DATE AS OF CHANGE: 20150812
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE INC
DATE OF NAME CHANGE: 19940719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JIGANTI JEANINE MARIE
CENTRAL INDEX KEY: 0001566865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 151048275
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
4
1
edgar.xml
FORM 4 -
X0306
4
2015-08-10
0
0000927066
DAVITA HEALTHCARE PARTNERS INC.
DVA
0001566865
JIGANTI JEANINE MARIE
2000 16TH STREET
DENVER
CO
80202
0
1
0
0
Chief Compliance Officer
Common Stock
2015-08-10
4
M
0
938
48.68
A
5000
D
Common Stock
2015-08-10
4
F
0
564
81.02
D
4436
D
Common Stock
2015-08-10
4
S
0
374
81.5034
D
4062
D
Common Stock
2015-08-10
4
S
0
937
81.2421
D
3125
D
Stock Appreciation Rights
48.68
2015-08-10
4
M
0
938
0.00
D
2013-07-09
2017-07-09
Common Stock
938
3750
D
This amount includes 212 shares acquired under Issuer's employee stock purchase plan on 12/31/2014.
Represents the weighted average sale price of $81.2421. The range of prices for the sale of these shares was $81.241 - $81.243, rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The Stock Appreciation Rights were granted on 7/9/2012 and vested 25% on 7/9/2013, then 6.25% every three months thereafter.
by Arturo Sida as attorney-in-fact
2015-08-12